United States Biotechnology & Medical Research

Novadel Pharma Inc (NVDL)

Track

Track

Novadel Pharma Inc has recorded no insider trading activity within the last three months. The most recent transactions occurred on March 31, 2010, involving a purchase by Jay Moorin. Historical records indicate various acquisition patterns by executives and other stakeholders prior to this date.
Ticker: NVDL Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Moorin Jay Large shareholder
Transaction date
Purchase
Price
289.24
Quantity 58,607 +10.8%
Value US$466,218
RATOFF STEVEN B Chief Executive Officer Executive Director
Transaction date
Purchase
Price
338.43
Quantity 40,176 -26.1%
Value US$3,647,890
RATOFF STEVEN B Chief Executive Officer Executive Director
Transaction date
Purchase
Price
406.97
Quantity 88,041 -36.0%
Value US$3,263,330
RATOFF STEVEN B Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.18
Quantity 465,800 +43.9%
Value US$81,701
RATOFF STEVEN B Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.15
Quantity 236,134 +28.7%
Value US$35,326
RATOFF STEVEN B Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.14
Quantity 263,866 +47.1%
Value US$37,179
HAMILTON WILLIAM F PHD Non-Executive Director
Transaction date
Purchase
Price
0.80
Quantity 4,000 +80.0%
Value US$3,200
Bonney Thomas E Non-Executive Director
Transaction date
Purchase
Price
0.79
Quantity 5,300 +26.5%
Value US$4,187
Baric Mark J Non-Executive Director
Transaction date
Purchase
Price
0.80
Quantity 4,900 +4900.0%
Value US$3,920
HAMILTON WILLIAM F PHD Non-Executive Director
Transaction date
Purchase
Price
0.68
Quantity 4,900 +4900.0%
Value US$3,332
HAMILTON WILLIAM F PHD Non-Executive Director
Transaction date
Purchase
Price
0.68
Quantity 100 +inf%
Value US$68
RATOFF STEVEN B Non-Executive Director
Transaction date
Purchase
Price
0.73
Quantity 2,310 +0.9%
Value US$1,686
RATOFF STEVEN B Non-Executive Director
Transaction date
Purchase
Price
0.73
Quantity 3,600 +1.4%
Value US$2,628
Baric Mark J Non-Executive Director
Transaction date
Purchase
Price
0.69
Quantity 100 +inf%
Value US$69
Nemeroff Charles Non-Executive Director
Transaction date
Purchase
Price
0.68
Quantity 15,000 +inf%
Value US$10,200
Bergstrom David H SVP & Chief Operating Officer Officer
Transaction date
Purchase
Price
0.65
Quantity 40,000 +inf%
Value US$26,044
RATOFF STEVEN B Non-Executive Director
Transaction date
Purchase
Price
0.65
Quantity 6,300 +2.5%
Value US$4,095
RATOFF STEVEN B Non-Executive Director
Transaction date
Purchase
Price
0.65
Quantity 39,300 +18.8%
Value US$25,545
RATOFF STEVEN B Non-Executive Director
Transaction date
Purchase
Price
0.64
Quantity 4,400 +2.2%
Value US$2,830
RATOFF STEVEN B Non-Executive Director
Transaction date
Purchase
Price
0.61
Quantity 50,000 +32.4%
Value US$30,350
SPICER MICHAEL E B CFO and Corporate Secretary Officer
Transaction date
Purchase
Price
0.66
Quantity 22,400 +134.9%
Value US$14,784
SPICER MICHAEL E B CFO and Corporate Secretary Officer
Transaction date
Purchase
Price
0.64
Quantity 3,500 +26.7%
Value US$2,240
RATOFF STEVEN B Non-Executive Director
Transaction date
Purchase
Price
0.60
Quantity 25,000 +19.4%
Value US$14,925
SPICER MICHAEL E B CFO and Corporate Secretary Officer
Transaction date
Purchase
Price
0.63
Quantity 4,100 +45.6%
Value US$2,583
ProQuest Investments III, L.P. Large shareholder
Transaction date
Purchase
Price
1.45
Quantity 763,449 +18.1%
Value US$1,107,001
Moorin Jay Large shareholder
Transaction date
Purchase
Price
1.45
Quantity 961,914 +18.1%
Value US$1,394,775
Bonney Thomas E Non-Executive Director
Transaction date
Purchase
Price
1.32
Quantity 19,500 +inf%
Value US$25,740
SPICER MICHAEL E B Chief Financial Officer Officer
Transaction date
Purchase
Price
1.38
Quantity 1,500 +20.0%
Value US$2,070
LOBELL J JAY Non-Executive Director
Transaction date
Purchase
Price
1.58
Quantity 31,646 +21.7%
Value US$50,001
RATOFF STEVEN B Non-Executive Director
Transaction date
Purchase
Price
1.58
Quantity 129,090 +inf%
Value US$203,962
Moorin Jay Large shareholder
Transaction date
Purchase
Price
1.45
Quantity 689,656 +14.9%
Value US$1,000,001
SPICER MICHAEL E B Chief Financial Officer Officer
Transaction date
Purchase
Price
1.18
Quantity 5,000 +200.0%
Value US$5,900
SPICER MICHAEL E B Chief Financial Officer Officer
Transaction date
Purchase
Price
1.20
Quantity 2,500 +inf%
Value US$3,000
Shangold Gary A President & CEO Executive Director
Transaction date
Purchase
Price
1.23
Quantity 7,500 +10.9%
Value US$9,225
Shangold Gary A President & CEO Executive Director
Transaction date
Purchase
Price
1.22
Quantity 16,500 +31.7%
Value US$20,130
Shangold Gary A President & CEO Executive Director
Transaction date
Purchase
Price
1.21
Quantity 1,000 +2.0%
Value US$1,210
Shangold Gary A President & CEO Executive Director
Transaction date
Purchase
Price
1.22
Quantity 1,000 +2.0%
Value US$1,220
Shangold Gary A President & CEO Officer
Transaction date
Purchase
Price
1.55
Quantity 21,700 +76.7%
Value US$33,635
Shangold Gary A President & CEO Officer
Transaction date
Purchase
Price
1.50
Quantity 18,300 +183.0%
Value US$27,450
Shangold Gary A President & CEO Officer
Transaction date
Purchase
Price
1.49
Quantity 8,600 +614.3%
Value US$12,814
Shangold Gary A President & CEO Officer
Transaction date
Purchase
Price
1.48
Quantity 1,400 +inf%
Value US$2,072
Cohen Barry VP, Product & Business Dev Officer
Transaction date
Purchase
Price
1.47
Quantity 5,000 +inf%
Value US$7,350
DUGGER HARRY A III PH D Chief Scientific Officer
Transaction date
Planned sale
Price
1.90
Quantity 7,700 -0.7%
Value US$14,630
DUGGER HARRY A III PH D Chief Scientific Officer
Transaction date
Planned sale
Price
1.92
Quantity 7,700 -0.7%
Value US$14,784
DUGGER HARRY A III PH D Chief Scientific Officer
Transaction date
Planned sale
Price
2.00
Quantity 7,700 -0.7%
Value US$15,400
DUGGER HARRY A III PH D Chief Scientific Officer
Transaction date
Planned sale
Price
1.90
Quantity 7,700 -0.7%
Value US$14,630
DUGGER HARRY A III PH D Chief Scientific Officer
Transaction date
Planned sale
Price
1.90
Quantity 7,700 -0.7%
Value US$14,630
SCHAUL ROBERT F Non-Executive Director
Transaction date
Sale
Price
1.70
Quantity 5,000 -20.6%
Value US$8,500
SCHAUL ROBERT F Non-Executive Director
Transaction date
Sale
Price
1.74
Quantity 5,000 -17.1%
Value US$8,700
SCHAUL ROBERT F Non-Executive Director
Transaction date
Sale
Price
1.75
Quantity 10,000 -25.5%
Value US$17,500
ROSENWALD LINDSAY A MD Large shareholder
Transaction date
Purchase
Price
1.59
Quantity 5,000 +0.1%
Value US$7,950
ROSENWALD LINDSAY A MD Large shareholder
Transaction date
Purchase
Price
1.66
Quantity 3,000 +0.1%
Value US$4,980
ROSENWALD LINDSAY A MD Large shareholder
Transaction date
Purchase
Price
1.64
Quantity 3,000 +0.1%
Value US$4,920
KESSEL LARRY Non-Executive Director
Transaction date
Purchase
Price
1.05
Quantity 20,204 +inf%
Value US$21,214
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2010-04-01 2010-03-31 B Purchase Moorin Jay Large shareholder
58,607 +10.8%
289.24
US$466,218 		58,607 +10.8% 289.24 US$466,218
2009-12-14 2009-12-11 B Purchase RATOFF STEVEN B

Chief Executive Officer

Executive Director
40,176 -26.1%
338.43
US$3,647,890 		40,176 -26.1% 338.43 US$3,647,890
2009-12-14 2009-12-11 B Purchase RATOFF STEVEN B

Chief Executive Officer

Executive Director
88,041 -36.0%
406.97
US$3,263,330 		88,041 -36.0% 406.97 US$3,263,330
2009-12-14 2009-12-11 B Purchase RATOFF STEVEN B

Chief Executive Officer

Executive Director
465,800 +43.9%
0.18
US$81,701 		465,800 +43.9% 0.18 US$81,701
2009-12-14 2009-12-08 B Purchase RATOFF STEVEN B

Chief Executive Officer

Executive Director
236,134 +28.7%
0.15
US$35,326 		236,134 +28.7% 0.15 US$35,326
2009-12-14 2009-12-08 B Purchase RATOFF STEVEN B

Chief Executive Officer

Executive Director
263,866 +47.1%
0.14
US$37,179 		263,866 +47.1% 0.14 US$37,179
2007-09-04 2007-08-30 B Purchase HAMILTON WILLIAM F PHD Non-Executive Director
4,000 +80.0%
0.80
US$3,200 		4,000 +80.0% 0.80 US$3,200
2007-08-31 2007-08-30 B Purchase Bonney Thomas E Non-Executive Director
5,300 +26.5%
0.79
US$4,187 		5,300 +26.5% 0.79 US$4,187
2007-08-29 2007-08-29 B Purchase Baric Mark J Non-Executive Director
4,900 +4900.0%
0.80
US$3,920 		4,900 +4900.0% 0.80 US$3,920
2007-09-04 2007-08-28 B Purchase HAMILTON WILLIAM F PHD Non-Executive Director
4,900 +4900.0%
0.68
US$3,332 		4,900 +4900.0% 0.68 US$3,332
2007-09-04 2007-08-28 B Purchase HAMILTON WILLIAM F PHD Non-Executive Director
100 +inf%
0.68
US$68 		100 +inf% 0.68 US$68
2007-08-29 2007-08-28 B Purchase RATOFF STEVEN B Non-Executive Director
2,310 +0.9%
0.73
US$1,686 		2,310 +0.9% 0.73 US$1,686
2007-08-29 2007-08-28 B Purchase RATOFF STEVEN B Non-Executive Director
3,600 +1.4%
0.73
US$2,628 		3,600 +1.4% 0.73 US$2,628
2007-08-29 2007-08-28 B Purchase Baric Mark J Non-Executive Director
100 +inf%
0.69
US$69 		100 +inf% 0.69 US$69
2007-08-28 2007-08-27 B Purchase Nemeroff Charles Non-Executive Director
15,000 +inf%
0.68
US$10,200 		15,000 +inf% 0.68 US$10,200
2007-08-28 2007-08-24 B Purchase Bergstrom David H

SVP & Chief Operating Officer

Officer
40,000 +inf%
0.65
US$26,044 		40,000 +inf% 0.65 US$26,044
2007-08-27 2007-08-24 B Purchase RATOFF STEVEN B Non-Executive Director
6,300 +2.5%
0.65
US$4,095 		6,300 +2.5% 0.65 US$4,095
2007-08-24 2007-08-23 B Purchase RATOFF STEVEN B Non-Executive Director
39,300 +18.8%
0.65
US$25,545 		39,300 +18.8% 0.65 US$25,545
2007-08-23 2007-08-22 B Purchase RATOFF STEVEN B Non-Executive Director
4,400 +2.2%
0.64
US$2,830 		4,400 +2.2% 0.64 US$2,830
2007-08-22 2007-08-21 B Purchase RATOFF STEVEN B Non-Executive Director
50,000 +32.4%
0.61
US$30,350 		50,000 +32.4% 0.61 US$30,350
2007-08-21 2007-08-20 B Purchase SPICER MICHAEL E B

CFO and Corporate Secretary

Officer
22,400 +134.9%
0.66
US$14,784 		22,400 +134.9% 0.66 US$14,784
2007-08-21 2007-08-20 B Purchase SPICER MICHAEL E B

CFO and Corporate Secretary

Officer
3,500 +26.7%
0.64
US$2,240 		3,500 +26.7% 0.64 US$2,240
2007-08-21 2007-08-20 B Purchase RATOFF STEVEN B Non-Executive Director
25,000 +19.4%
0.60
US$14,925 		25,000 +19.4% 0.60 US$14,925
2007-08-21 2007-08-20 B Purchase SPICER MICHAEL E B

CFO and Corporate Secretary

Officer
4,100 +45.6%
0.63
US$2,583 		4,100 +45.6% 0.63 US$2,583
2007-01-26 2007-01-05 B Purchase ProQuest Investments III, L.P. Large shareholder
763,449 +18.1%
1.45
US$1,107,001 		763,449 +18.1% 1.45 US$1,107,001
2007-01-26 2007-01-05 B Purchase Moorin Jay Large shareholder
961,914 +18.1%
1.45
US$1,394,775 		961,914 +18.1% 1.45 US$1,394,775
2006-07-05 2006-06-30 B Purchase Bonney Thomas E Non-Executive Director
19,500 +inf%
1.32
US$25,740 		19,500 +inf% 1.32 US$25,740
2006-06-27 2006-06-23 B Purchase SPICER MICHAEL E B

Chief Financial Officer

Officer
1,500 +20.0%
1.38
US$2,070 		1,500 +20.0% 1.38 US$2,070
2006-04-21 2006-04-19 B Purchase LOBELL J JAY Non-Executive Director
31,646 +21.7%
1.58
US$50,001 		31,646 +21.7% 1.58 US$50,001
2006-04-21 2006-04-19 B Purchase RATOFF STEVEN B Non-Executive Director
129,090 +inf%
1.58
US$203,962 		129,090 +inf% 1.58 US$203,962
2006-04-14 2006-04-12 B Purchase Moorin Jay Large shareholder
689,656 +14.9%
1.45
US$1,000,001 		689,656 +14.9% 1.45 US$1,000,001
2006-01-03 2005-12-29 B Purchase SPICER MICHAEL E B

Chief Financial Officer

Officer
5,000 +200.0%
1.18
US$5,900 		5,000 +200.0% 1.18 US$5,900
2005-07-01 2005-06-30 B Purchase SPICER MICHAEL E B

Chief Financial Officer

Officer
2,500 +inf%
1.20
US$3,000 		2,500 +inf% 1.20 US$3,000
2005-06-30 2005-06-29 B Purchase Shangold Gary A

President & CEO

Executive Director
7,500 +10.9%
1.23
US$9,225 		7,500 +10.9% 1.23 US$9,225
2005-06-30 2005-06-29 B Purchase Shangold Gary A

President & CEO

Executive Director
16,500 +31.7%
1.22
US$20,130 		16,500 +31.7% 1.22 US$20,130
2005-06-30 2005-06-29 B Purchase Shangold Gary A

President & CEO

Executive Director
1,000 +2.0%
1.21
US$1,210 		1,000 +2.0% 1.21 US$1,210
2005-06-30 2005-06-28 B Purchase Shangold Gary A

President & CEO

Executive Director
1,000 +2.0%
1.22
US$1,220 		1,000 +2.0% 1.22 US$1,220
2004-12-23 2004-12-23 B Purchase Shangold Gary A

President & CEO

Officer
21,700 +76.7%
1.55
US$33,635 		21,700 +76.7% 1.55 US$33,635
2004-12-23 2004-12-22 B Purchase Shangold Gary A

President & CEO

Officer
18,300 +183.0%
1.50
US$27,450 		18,300 +183.0% 1.50 US$27,450
2004-12-23 2004-12-22 B Purchase Shangold Gary A

President & CEO

Officer
8,600 +614.3%
1.49
US$12,814 		8,600 +614.3% 1.49 US$12,814
2004-12-23 2004-12-22 B Purchase Shangold Gary A

President & CEO

Officer
1,400 +inf%
1.48
US$2,072 		1,400 +inf% 1.48 US$2,072
2004-12-22 2004-12-22 B Purchase Cohen Barry

VP, Product & Business Dev

Officer
5,000 +inf%
1.47
US$7,350 		5,000 +inf% 1.47 US$7,350
2004-07-06 2004-07-02 PlS Planned sale
DUGGER HARRY A III PH D

Chief Scientific Officer
7,700 -0.7%
1.90
US$14,630 		7,700 -0.7% 1.90 US$14,630
2004-07-06 2004-07-01 PlS Planned sale
DUGGER HARRY A III PH D

Chief Scientific Officer
7,700 -0.7%
1.92
US$14,784 		7,700 -0.7% 1.92 US$14,784
2004-06-30 2004-06-30 PlS Planned sale DUGGER HARRY A III PH D

Chief Scientific Officer
7,700 -0.7%
2.00
US$15,400 		7,700 -0.7% 2.00 US$15,400
2004-06-30 2004-06-29 PlS Planned sale DUGGER HARRY A III PH D

Chief Scientific Officer
7,700 -0.7%
1.90
US$14,630 		7,700 -0.7% 1.90 US$14,630
2004-06-30 2004-06-28 PlS Planned sale DUGGER HARRY A III PH D

Chief Scientific Officer
7,700 -0.7%
1.90
US$14,630 		7,700 -0.7% 1.90 US$14,630
2004-06-28 2004-06-24 S Sale SCHAUL ROBERT F Non-Executive Director
5,000 -20.6%
1.70
US$8,500 		5,000 -20.6% 1.70 US$8,500
2004-06-28 2004-06-24 S Sale SCHAUL ROBERT F Non-Executive Director
5,000 -17.1%
1.74
US$8,700 		5,000 -17.1% 1.74 US$8,700
2004-06-28 2004-06-24 S Sale SCHAUL ROBERT F Non-Executive Director
10,000 -25.5%
1.75
US$17,500 		10,000 -25.5% 1.75 US$17,500
2004-04-01 2004-03-31 B Purchase ROSENWALD LINDSAY A MD Large shareholder
5,000 +0.1%
1.59
US$7,950 		5,000 +0.1% 1.59 US$7,950
2004-03-31 2004-03-30 B Purchase ROSENWALD LINDSAY A MD Large shareholder
3,000 +0.1%
1.66
US$4,980 		3,000 +0.1% 1.66 US$4,980
2004-03-30 2004-03-29 B Purchase ROSENWALD LINDSAY A MD Large shareholder
3,000 +0.1%
1.64
US$4,920 		3,000 +0.1% 1.64 US$4,920
2004-01-12 2004-01-08 B Purchase KESSEL LARRY Non-Executive Director
20,204 +inf%
1.05
US$21,214 		20,204 +inf% 1.05 US$21,214
Explore more

More insider trading research around Novadel Pharma Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America